Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Non-Current Assets (2020 - 2022)

Historic Non-Current Assets for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q3 2022 value amounting to $4.6 million.

  • Atea Pharmaceuticals' Non-Current Assets rose 73172.04% to $4.6 million in Q3 2022 from the same period last year, while for Sep 2022 it was $14.0 million, marking a year-over-year increase of 74690.91%. This contributed to the annual value of $489000.0 for FY2021, which is 21548.39% up from last year.
  • Atea Pharmaceuticals' Non-Current Assets amounted to $4.6 million in Q3 2022, which was up 73172.04% from $4.9 million recorded in Q2 2022.
  • Over the past 5 years, Atea Pharmaceuticals' Non-Current Assets peaked at $4.9 million during Q2 2022, and registered a low of $155000.0 during Q4 2020.
  • Its 3-year average for Non-Current Assets is $1.9 million, with a median of $558000.0 in 2021.
  • As far as peak fluctuations go, Atea Pharmaceuticals' Non-Current Assets tumbled by 6704.08% in 2021, and later surged by 102863.74% in 2022.
  • Quarter analysis of 3 years shows Atea Pharmaceuticals' Non-Current Assets stood at $155000.0 in 2020, then surged by 215.48% to $489000.0 in 2021, then soared by 849.08% to $4.6 million in 2022.
  • Its Non-Current Assets was $4.6 million in Q3 2022, compared to $4.9 million in Q2 2022 and $4.0 million in Q1 2022.